ResMed (RMD) Stock Forecast & Price Prediction

Estimation of the future price movement of ResMed stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target

Current $174.61

Concensus $217.80

Low $175.00

Median $240.00

High $250.00

Based on analysts projections #RMD is expected to experience a positive growth trajectory over the next year.

The current average RMD price target, as estimated by these analysts, is $217.80.

The predictions for the future RMD stock price range from a low of $175.00 to a high of $250.00, highlighting the variability of market expectations for RMD.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

RMD stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Suraj Kalia
October 27, 2023 Buy 175.00 134.65
Mike Matson
September 6, 2023 Buy 180.00 153.89
Craig Wong-Pan
RBC Capital
June 20, 2022 Buy 244.00 197.57
RBC Capital April 29, 2022 Buy 233.00 200.81
Suraj Kalia
October 14, 2021 Buy 312.00 253.77
Sean Laaman
Morgan Stanley
August 4, 2021 Buy 250.00 271.87
Anthony Petrone
July 28, 2021 Buy 240.00 264.75

ResMed (RMD) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if ResMed is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Strong Buy

Financial Scores

Updated on: 02/03/2024

Altman Z-Score: 8.7

Piotroski Score: 5.0

ESG Score

Updated on: 02/03/2024

Environmental: 62.8

Social: 73.0

Governance: 65.8

Financial Health

Updated on: 02/03/2024

DCF: Buy

ROE: Buy

ROA: Strong Buy

Debt to equity ratio: Buy

Price to earnings ratio: Strong Buy

Price to book ratio: Strong Buy

RMD Discounted Cash Flow

Updated on: 02/03/2024

Discounted Cash Flow Value

Current Price

RMD Revenues by Segment

Updated on: 02/03/2024

Sleep And Respiratory
Software As A Service

Revenue from Contract with Customer, Excluding Assessed Tax

RMD Revenues by Region

Updated on: 02/03/2024

Rest Of World

RMD Notes Due

Updated on: 02/03/2024


There are no data to display

ResMed (RMD) Social Sentiments

Monitoring bullish and bearish sentiments towards ResMed on Twitter and Stocktwits could help to forecast an upward or downward trend in ResMed stock price.

No social results for RMD

Positive Stock Forecast for ResMed: Capitalizing on Growth in Medical Instruments & Supplies Sector

ResMed (RMD) is a medical devices company that develops and manufactures equipment for the treatment of sleep apnea and other respiratory disorders. The company’s products include continuous positive airway pressure (CPAP) machines, masks, and accessories that help patients breathe better during sleep. ResMed’s strong position in the market has enabled it to generate a steady stream of revenue from its... Read more

ResMed (RMD): A Strong Contender in the Medical Instruments & Supplies Stock Market Sector with Positive Predictions

The Medical Instruments & Supplies stock market sector has been a popular investment choice for many years due to the constantly increasing demand for medical products and technological advancements in healthcare. With an ever-growing population and aging baby boomers, this sector is expected to continue its growth trajectory. One of the most prominent companies in this industry is ResMed (RMD),... Read more